The table below shows VERTEX PHARMACEUTICALS INC / MA's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$12.00B
$11.02B
$9.87B
$8.93B
$7.57B
$6.21B
Cost of revenue
$1.65B
$1.53B
$1.26B
$1.08B
$904.20M
$736.30M
Gross profit
-
-
-
-
-
-
R&D
-
-
-
-
$3.05B
$1.83B
SG&A
VRTX annual revenue (10-K history)
VERTEX PHARMACEUTICALS INC / MA reported annual revenue of $12.00B for fiscal year 2025. That is up 8.9% from $11.02B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $1.70B (FY 2016) to $12.00B. Figures come from the company's audited annual reports as filed with the SEC.
